论文部分内容阅读
目的观察舒利迭(沙美特罗/氟替卡松)治疗支气管哮喘的疗效。方法对120例确诊支气管哮喘的患者,分为吸入糖皮质激素和长效β2受体激动剂的复方制剂舒利迭(沙美特罗/氟替卡松)治疗组60例,吸入糖皮质激素(丙酸氟替卡松)对照组60例。治疗后对临床疗效、肺功能指标进行比较及统计学分析。结果舒利迭治疗组用药后临床疗效和肺功能改善方面明显优于对照组。结论舒利迭在治疗支气管哮喘改善临床症状和肺功能明显,较单纯吸入糖皮质激素能更好控制及改善的哮喘症状。
Objective To observe the efficacy of seretide (salmeterol / fluticasone) in the treatment of bronchial asthma. Methods A total of 120 patients diagnosed with bronchial asthma were divided into 60 patients treated with the compound preparation of salmeteril (salmeterol / fluticasone) inhaled glucocorticoid and long-acting β 2 receptor agonist. The patients were given glucocorticoid (fluticasone propionate ) Control group of 60 cases. After treatment, the clinical efficacy and pulmonary function indicators were compared and statistically analyzed. Results Seretide treatment group was significantly better than the control group in clinical efficacy and improvement of pulmonary function after treatment. Conclusion Seretide in the treatment of bronchial asthma to improve clinical symptoms and lung function significantly better than simple inhaled corticosteroids can better control and improve the symptoms of asthma.